Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options
- Status
- COMPLETED
- Phase
- NA
Niraparib in Patients With Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Osimertinib In EGFR Mutant Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Acalabrutinib, Venetoclax, and Obinutuzumab for Initial Therapy of CLL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
The GI Binder: A Psychoeducational Intervention for Gastrointestinal Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Sexual Health and Rehabilitation After Ovarian Suppression Treatment
- Status
- COMPLETED
- Phase
- NA
Mathematical Model-Adapted Radiation In Glioblastoma
- Status
- COMPLETED
- Phase
- NA
Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes
- Status
- COMPLETED
- Phase
- N/A
Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Clinician Decision Support Algorithm for Chemotherapy-Induced Peripheral Neuropathy
- Status
- COMPLETED
- Phase
- NA
Translating Research Into Practice: Patient Navigation for Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyperplasia
- Status
- TERMINATED
- Phase
- NA
A Study of Prexasertib (LY2606368), CHK1 Inhibitor, and LY3300054, PD-L1 Inhibitor, in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Comparing Restriction Spectrum Imaging (RSI) to Conventional and Abbreviated Breast MRI for Breast Cancer Screening
- Status
- COMPLETED
- Phase
- NA
Study of Venetoclax, a BCL2 Antagonist, for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- Status
- COMPLETED
- Phase
- PHASE1
Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis
- Status
- COMPLETED
- Phase
- PHASE2
Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening
- Status
- COMPLETED
- Phase
- NA